Dg. Barnes et al., BENCHMARK DOSE WORKSHOP - CRITERIA FOR USE OF A BENCHMARK DOSE TO ESTIMATE A REFERENCE DOSE, Regulatory toxicology and pharmacology, 21(2), 1995, pp. 296-306
The purpose of the Benchmark Dose Workshop was to assess the feasibili
ty and implications of replacing the no observed adverse effect level
(NOAEL) with a benchmark dose (BRID) when deriving reference doses and
concentrations (RfDs and RfCs). The workshop participants supported t
he use of the BMD method to remove many of the limitations inherent in
using the NOAEL approach, Participants endorsed in general the use of
a BMD for all quantal noncancer health effects and endorsed in partic
ular the BMD for assessing developmental toxicity based on data presen
ted at the workshop. The discussions of implementation recognized the
need to demonstrate that changing from a NOAEL to a BMD gives the risk
manager more certain information on which to base decisions, Most par
ticipants agreed that the current NOAEL-derived RfDs and RfCs are suff
iciently protective and should only be changed as data become availabl
e for estimating a BMD, It was recognized that to achieve general acce
ptance of the BMD approach, it will have to be applied to a variety of
endpoints. (C) 1995 Academic Press, Inc.